MedTech success stories
Resonance Therapeutics (RTx)
RTx is building a non-invasive neuromodulation system that can measure, analyse and stimulate the brain, providing uniquely personalised treatment for depression for use in the home.
Johnson & Johnson Innovation
JJIPO@MONASH facilitates access by Victorian researchers and companies to the expertise across Johnson & Johnson’s scientist research, investor and commercial business arms.
In a bid to prevent death during childbirth as a consequence of unchecked postpartum haemorrhage, Monash researchers have collaborated with healthcare workers and women in developing countries to design an oxytocin inhaler that can be used with minimal training, is stable at room temperature and resistant to degradation.
Spin-out: The MoodMission smartphone app is designed to be used by anyone, whether they have a clinically significant anxiety or mood disorder, or just want to find ways of coping with day-to-day feelings of anxiousness or low moods.
Haemokinesis – Blood group testing
Collaboration between Monash and Haemokinesis Pty Ltd has resulted in a momentous breakthrough for world health: the creation of a novel category of low cost paper diagnostics that can identify a person’s blood group in just one minute.
Erler Zimmer – Anatomical models
Making use of a range of technologies, the Monash Centre for Human Anatomy Education has created 3D prints of the entire human body. These anatomically correct, coloured plastic prints can be purchased at a fraction of the cost of an embalmed or plastinated body.
4D Medical (ASX:4DX)
Spin-out: Four-dimensional x-ray imaging technology developed by Monash Engineering is providing state-of-the-art, non-invasive ways of understanding real time lung motion and airflow.
Low FODMAP diet app
Spin-out: Launched in response to an increasing number of requests about the FODMAP content of foods, the Monash University Low FODMAP diet smartphone application helps users manage symptoms of IBS by restricting foods that are high in certain short-chain-carbohydrates.
The Gennaris bionic vision system is being designed to bypass damaged optic nerves, making it possible to treat many conditions for which other technologies have limited benefit.
World Mosquito Program
With a uniquely self-sustaining method, the World Mosquito Program has the potential to transform the global fight against life-threatening viral diseases.
Spin-out: The Monash In Vitro Fertilisation research program resulted in the first human IVF pregnancy in 1973. Monash IVF have continued to achieve many Australian and world firsts, enabling new technologies to be delivered to patients as soon as they're available.
Acrux – Drug delivery
Spin-out: Acrux is a spin-off biotech company from Monash, recognised for its innovative technology in administering drugs through the skin.